Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the first Trump Administration, though the portions of the order relating to the ...
WASHINGTON, DC - SEPTEMBER 30: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with the company to lower Medicaid drug prices and to sell certain ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the program continues. In the two years since the first case challenging the program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results